Real-time enrollment status for this hormone-refractory prostate cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 8:42 AM UTC
| NCT Number | NCT05997615 |
| Recruiting Status | Recruiting |
| Condition | Hormone-refractory Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 437 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Vir Biotechnology, Inc. |
| Last Updated on CT.gov | August 24, 2026 (1 week ago) |
As of September 1, 2026: Clinical trial NCT05997615 is currently recruiting participants. This phase1 study for hormone-refractory prostate cancer is actively seeking new participants at 4 locations across the United States. The study is sponsored by Vir Biotechnology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05997615 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05997615 was last updated 1 week ago (August 24, 2026). HelloStudys verifies this status automatically.